BPA Call HT001414A0010-0002
Award Date
9/15/15
Potential Completion Date
9/30/16
Potential Value
$135K
Federal Agency
Defense Health Agency
Awardee
Biofire Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $480,000.00 firm fixed price contract provides reagents and instruments such as a pneumonia verification kit, respiratory panel, and blood culture identification panel. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $500,000.00 contract is for reagents to support the Walter Reed National Military Medical Center laboratory. The BPA is under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. Biofire Diagnostics has...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $1,353,678.46, is a Blanket Purchase Agreement (BPA) call order for the delivery of reagents. This contract supports the VA's infectious disease testing capabilities and is part of a larger indefinite delivery vehicle that Biofire Diagnostics holds...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 20 to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $708,924.28 contract is for the supply of reagents and consumables through January 31, 2026. Biofire Diagnostics LLC has received numerous federal contracts and holds various indefinite delivery/indefinite quantity (IDIQ) contracts and blanket...
This is a firm-fixed-price BPA call order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 to Biofire Diagnostics LLC, a private sector biotech company. The contract is for the provision of Biofire syndromic infectious disease testing panels and reagents, with a ceiling value of $115,473.75 and a performance period through June 29, 2023. This order is placed against Biofire's existing General Services Administration (GSA) Federal Supply...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $117,641.50 firm-fixed-price contract is for FILMARRAY DIAGNOSTICS TESTING services, ordered via a Blanket Purchase Agreement (BPA) call against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Biofire Diagnostics LLC, a for-profit biotech company specializing in syndromic infectious disease testing. The contract, valued at $443,642.40, is for the supply of Biofire Film Array reagents. The contract has a period of performance through September 30, 2024. Biofire Diagnostics LLC holds multiple indefinite delivery and blanket purchase...
This contract was awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide reagents and consumables for the Walter Reed National Military Medical Center laboratory. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The potential value of the contract is $500,000, and it has a completion date of...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call award by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $186,000.00 contract is for Biofire's IVD, Reagents, and Test products and services, procured against Biofire's General Services Administration (GSA) Federal Supply Schedule contract. The contract has a September 30, 2023 completion date and was...
The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...